Presented By:
Anne-Geneviève Marcelin
Professor of virology at Sorbonne Université, Clinical virologist at Pitié-Salpêtrière Hospital
Jean-François Mouscadet
Associate Vice President of Research & Development, Bio-Rad Laboratories, Clinical Diagnostics
Heidi Scholz
Research & Development Manager, Bio-Rad Laboratories – Clinical Immunology
Webinar:
Two years into the COVID-19 pandemic… What can serology testing tell us about immune status?
Webinar Abstract:
As of May 2022, there have been more than 500 million confirmed cases of COVID-19. Additionally, more than 5 billion people have received at least one dose of a COVID-19 vaccine. Immune responses to natural COVID-19 infections, including to the numerous variants and subvariants, and to the variety of available vaccines are unique.
Two years into the global COVID-19 pandemic, the role of serology testing to evaluate immune responses has not yet been defined. This webinar will explore the role of serology testing to assess immune status.
Bio-Rad SARS-CoV-2 products provide you and your laboratory with efficient new ways to quantitatively characterize immune responses.
LabRoots on Social:
Facebook: https://www.facebook.com/LabRootsInc
Twitter: https://twitter.com/LabRoots
LinkedIn: https://www.linkedin.com/company/labroots
Instagram: https://www.instagram.com/labrootsinc
Pinterest: https://www.pinterest.com/labroots/
SnapChat: labroots_inc
